SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Ionis Pharmaceuticals (IONS)
An SI Board Since May 1996
Posts SubjectMarks Bans Symbol
4676 121 0 IONS
Emcee:  Keith Fauci Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
3951Targeting MicroRNAs With Antisense Drugs Produces Compelling Preclinical Data inbob zagorin-6/12/2006
3950Isis Pharmaceuticals Receives Orphan Drug Status for ISIS 301012 for the Treatmebob zagorin-6/1/2006
3949the most encouraging thing in all that imo is clear signals that something is cobob zagorin-5/31/2006
3948three filings.. allare interesting. first is details on azimuth; second prospectbob zagorin-5/31/2006
3947Isis Pharmaceuticals Receives $75 Million Equity Financing Commitment Tuesday Mabob zagorin-5/30/2006
3946Web address: sciencedaily.com Source: Northwestern University Posted: May 19,bob zagorin-5/22/2006
3945from zacks.. Target Price Updates Symbol Broker From To Date ISIS Mbob zagorin-5/12/2006
394410q xml.10kwizard.combob zagorin-5/10/2006
3943Looking For Cash, Isis Strikes Rare Licensing Deal By CHRISTOPHER HINTON May 3, bob zagorin-5/5/2006
3942truth is i had a lot and sold some of the position on runup close to 9. but i acbob zagorin-5/3/2006
3941Bob Z--Over the past 2 months I've been accumulating Isis based on their proJOEBT1-5/3/2006
3940from zacks... Target Price Updates Symbol Broker From To Date ISIS bob zagorin-5/3/2006
3939Isis Pharmaceuticals Reports Financial Results and Highlights for First Quarter bob zagorin-5/2/2006
3938repost from yhoo.. worth reading.. "...What's the big picture of the nbob zagorin-4/28/2006
3937Isis Pharmaceuticals Reports Positive Phase 2 Data: ISIS 301012 Reduces Cholestebob zagorin-4/27/2006
3936ISIS 301012 Reduces Atherosclerotic Plaques in Animal Models Thursday April 27, bob zagorin-4/27/2006
3935Isis Pharmaceuticals Licenses Anti-HIV Drug to ImQuest Pharmaceuticals Tuesday Abob zagorin-4/18/2006
3934the market does not agree for some reasonrjk01-4/11/2006
3933pretty good review of call and deal from yahoo thread... "...Re: The Deal bob zagorin-4/11/2006
3932in fact, dj has moved a story quoting an analyst who said the market is disappoibob zagorin-4/10/2006
3931not sure. must have something to do with the symphony financing.. perhaps disappbob zagorin-4/10/2006
3930why the price drop?rjk01-4/10/2006
39298k filing on symphony deal xml.10kwizard.combob zagorin-4/10/2006
3928Forbes.com Biotechnology Biotech's Financial Lifeline Kerry A. Dolan, 04.10bob zagorin-4/10/2006
3927Isis Pharmaceuticals and Symphony GenIsis Enter Into $75 Million Product Developbob zagorin-4/7/2006
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News